Glioma Treatment Market Key Players and Forecast by 2030
Glioma Treatment Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
- Status : Published
- Report Code : TIPRE00029993
- Category : Life Sciences
- No. of Pages : 182
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Disease, Treatment Type, Grade, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global glioma treatment market, by treatment type, is segmented into surgery, chemotherapy, radiation therapy, and others. The other treatments include targeted drug therapy, electric and magnetic fields, and combination therapies. In 2022, the surgery segment held the largest share of the glioma treatment market. It is further estimated to register a significant CAGR during the forecast period.
Global glioma treatment market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the glioma treatment market during 2022–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.
Companies operating in the market are F. Hoffmann-La Roche Ltd; Arbor Pharmaceuticals, LLC; Merck and Co., Inc.; Sun Pharmaceutical Industries Ltd; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Pfizer Inc.; Amneal Pharmaceuticals, LLC; Karyopharm Therapeutics, Inc.; and Biocon Ltd.
Glioma is a condition that covers a broad category of brain and spinal cord tumors that concern the glial cells in the brain function and can be fatal depending on the location and severity of the tumor. Astrocytoma, brainstem gliomas, ependymoma, mixed gliomas, oligodendrogliomas, and optic pathway gliomas are the various types of gliomas. Common glioma symptoms include headache, nausea, vomiting, confusion, and a decline in brain function. Glioma can be treated in a variety of ways which include radiation therapy for glioma, chemotherapy, glioma-targeted therapy, and surgery. Effective treatment of glioma may be available from late clinical pipeline drugs.
Based on disease, the glioma treatment market is segmented into astrocytoma, oligoastrocytoma, and oligodendroglioma. In 2022, the astrocytoma segment held the largest share of the market. The same segment is estimated to record at a significant CAGR of during the forecast period.
Increasing various initiatives undertaken by the regional and state governments to provide patients access to treatment and increase in prevalence of high-grade glioma are the key driving factors behind the market development.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Glioma Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Glioma Treatment Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Initiatives by Regional and State Governments to Provide Patients Access to Treatment
5.1.2 Increase in Prevalence of High-Grade Glioma
5.2 Key Market Restraints
5.2.1 High Cost of Diagnosis
5.3 Key Market Opportunities
5.3.1 Advancements in Healthcare Sector in Emerging Economies
5.4 Future Trends
5.4.1 Surge in Drug Approvals for Glioma Treatment
5.5 Impact Analysis:
6. Glioma Treatment Market - Global Market Analysis
6.1 Glioma Treatment Market Revenue (US$ Mn), 2022 – 2030
7. Global Glioma Treatment Market – Revenue and Forecast to 2030 – by Disease
7.1 Overview
7.2 Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
7.3 Astrocytoma
7.3.1 Overview
7.3.2 Astrocytoma: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Oligoastrocytoma
7.4.1 Overview
7.4.2 Oligoastrocytoma: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Oligodendroglioma
7.5.1 Overview
7.5.2 Oligodendroglioma: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Glioma Treatment Market – Revenue and Forecast to 2030 – by Treatment Type
8.1 Overview
8.2 Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
8.3 Surgery
8.3.1 Overview
8.3.2 Surgery: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Chemotherapy
8.4.1 Overview
8.4.2 Chemotherapy: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Radiation Therapy
8.5.1 Overview
8.5.2 Radiation Therapy: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Glioma Treatment Market – Revenue and Forecast to 2030 – by Grade
9.1 Overview
9.2 Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
9.3 Low Grade
9.3.1 Overview
9.3.2 Low Grade: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.3.2.1 Grade I: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.3.2.2 Grade II: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.4 High Grade
9.4.1 Overview
9.4.2 High Grade: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.1 Grade III: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.2 Grade IV: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10. Global Glioma Treatment Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospital & Clinics
10.3.1 Overview
10.3.2 Hospital & Clinics: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11. Glioma Treatment Market - Geographical Analysis
11.1 North America Glioma Treatment Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3 North America Glioma Treatment Market, by Disease
11.1.4 North America Glioma Treatment Market, by Treatment Type
11.1.5 North America Glioma Treatment Market, by Grade
11.1.5.1 North America Glioma Treatment Market, by Low Grade
11.1.5.2 North America Glioma Treatment Market, by High Grade
11.1.6 North America Glioma Treatment Market, by End User
11.1.7 North America Glioma Treatment Market, by Country
11.1.7.1 US
11.1.7.1.1 US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.1.2 US Glioma Treatment Market, by Disease
11.1.7.1.3 US Glioma Treatment Market, by Treatment Type
11.1.7.1.4 US Glioma Treatment Market, by Grade
11.1.7.1.4.1 US Glioma Treatment Market, by Low Grade
11.1.7.1.4.2 US Glioma Treatment Market, by High Grade
11.1.7.1.5 US Glioma Treatment Market, by End User
11.1.7.2 Canada
11.1.7.2.1 Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.2.2 Canada Glioma Treatment Market, by Disease
11.1.7.2.3 Canada Glioma Treatment Market, by Treatment Type
11.1.7.2.4 Canada Glioma Treatment Market, by Grade
11.1.7.2.4.1 Canada Glioma Treatment Market, by Low Grade
11.1.7.2.4.2 Canada Glioma Treatment Market, by High Grade
11.1.7.2.5 Canada Glioma Treatment Market, by End User
11.1.7.3 Mexico
11.1.7.3.1 Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.3.2 Mexico Glioma Treatment Market, by Disease
11.1.7.3.3 Mexico Glioma Treatment Market, by Treatment Type
11.1.7.3.4 Mexico Glioma Treatment Market, by Grade
11.1.7.3.4.1 Mexico Glioma Treatment Market, by Low Grade
11.1.7.3.4.2 Mexico Glioma Treatment Market, by High Grade
11.1.7.3.5 Mexico Glioma Treatment Market, by End User
11.2 Europe Glioma Treatment Market, Revenue and Forecast to 2030
11.2.1 Overview
11.2.2 Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.2.3 Europe Glioma Treatment Market, by Disease
11.2.4 Europe Glioma Treatment Market, by Treatment Type
11.2.5 Europe Glioma Treatment Market, by Grade
11.2.5.1 Europe Glioma Treatment Market, by Low Grade
11.2.5.2 Europe Glioma Treatment Market, by High Grade
11.2.6 Europe Glioma Treatment Market, by End User
11.2.7 Europe Glioma Treatment Market, by Country
11.2.7.1 UK
11.2.7.1.1 UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.1.2 UK Glioma Treatment Market, by Disease
11.2.7.1.3 UK Glioma Treatment Market, by Treatment Type
11.2.7.1.4 UK Glioma Treatment Market, by Grade
11.2.7.1.4.1 UK Glioma Treatment Market, by Low Grade
11.2.7.1.4.2 UK Glioma Treatment Market, by High Grade
11.2.7.1.5 UK Glioma Treatment Market, by End User
11.2.7.2 Germany
11.2.7.2.1 Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.2.2 Germany Glioma Treatment Market, by Disease
11.2.7.2.3 Germany Glioma Treatment Market, by Treatment Type
11.2.7.2.4 Germany Glioma Treatment Market, by Grade
11.2.7.2.4.1 Germany Glioma Treatment Market, by Low Grade
11.2.7.2.4.2 Germany Glioma Treatment Market, by High Grade
11.2.7.2.5 Germany Glioma Treatment Market, by End User
11.2.7.3 France
11.2.7.3.1 France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.3.2 France Glioma Treatment Market, by Disease
11.2.7.3.3 France Glioma Treatment Market, by Treatment Type
11.2.7.3.4 France Glioma Treatment Market, by Grade
11.2.7.3.4.1 France Glioma Treatment Market, by Low Grade
11.2.7.3.4.2 France Glioma Treatment Market, by High Grade
11.2.7.3.5 France Glioma Treatment Market, by End User
11.2.7.4 Italy
11.2.7.4.1 Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.4.2 Italy Glioma Treatment Market, by Disease
11.2.7.4.3 Italy Glioma Treatment Market, by Treatment Type
11.2.7.4.4 Italy Glioma Treatment Market, by Grade
11.2.7.4.4.1 Italy Glioma Treatment Market, by Low Grade
11.2.7.4.4.2 Italy Glioma Treatment Market, by High Grade
11.2.7.4.5 Italy Glioma Treatment Market, by End User
11.2.7.5 Spain
11.2.7.5.1 Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.5.2 Spain Glioma Treatment Market, by Disease
11.2.7.5.3 Spain Glioma Treatment Market, by Treatment Type
11.2.7.5.4 Spain Glioma Treatment Market, by Grade
11.2.7.5.4.1 Spain Glioma Treatment Market, by Low Grade
11.2.7.5.4.2 Spain Glioma Treatment Market, by High Grade
11.2.7.5.5 Spain Glioma Treatment Market, by End User
11.2.7.6 Rest of Europe
11.2.7.6.1 Rest of Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.6.2 Rest of Europe Glioma Treatment Market, by Disease
11.2.7.6.3 Rest of Europe Glioma Treatment Market, by Treatment Type
11.2.7.6.4 Rest of Europe Glioma Treatment Market, by Grade
11.2.7.6.4.1 Rest of Europe Glioma Treatment Market, by Low Grade
11.2.7.6.4.2 Rest of Europe Glioma Treatment Market, by High Grade
11.2.7.6.5 Rest of Europe Glioma Treatment Market, by End User
11.3 Asia Pacific Glioma Treatment Market, Revenue and Forecast to 2030
11.3.1 Overview
11.3.2 Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3 Asia Pacific Glioma Treatment Market, by Disease
11.3.4 Asia Pacific Glioma Treatment Market, by Treatment Type
11.3.5 Asia Pacific Glioma Treatment Market, by Grade
11.3.5.1 Asia Pacific Glioma Treatment Market, by Low Grade
11.3.5.2 Asia Pacific Glioma Treatment Market, by High Grade
11.3.6 Asia Pacific Glioma Treatment Market, by End User
11.3.7 Asia Pacific Glioma Treatment Market, by Country
11.3.7.1 China
11.3.7.1.1 China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.1.2 China Glioma Treatment Market, by Disease
11.3.7.1.3 China Glioma Treatment Market, by Treatment Type
11.3.7.1.4 China Glioma Treatment Market, by Grade
11.3.7.1.4.1 China Glioma Treatment Market, by Low Grade
11.3.7.1.4.2 China Glioma Treatment Market, by High Grade
11.3.7.1.5 China Glioma Treatment Market, by End User
11.3.7.2 Japan
11.3.7.2.1 Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.2.2 Japan Glioma Treatment Market, by Disease
11.3.7.2.3 Japan Glioma Treatment Market, by Treatment Type
11.3.7.2.4 Japan Glioma Treatment Market, by Grade
11.3.7.2.4.1 Japan Glioma Treatment Market, by Low Grade
11.3.7.2.4.2 Japan Glioma Treatment Market, by High Grade
11.3.7.2.5 Japan Glioma Treatment Market, by End User
11.3.7.3 India
11.3.7.3.1 India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.3.2 India Glioma Treatment Market, by Disease
11.3.7.3.3 India Glioma Treatment Market, by Treatment Type
11.3.7.3.4 India Glioma Treatment Market, by Grade
11.3.7.3.4.1 India Glioma Treatment Market, by Low Grade
11.3.7.3.4.2 India Glioma Treatment Market, by High Grade
11.3.7.3.5 India Glioma Treatment Market, by End User
11.3.7.4 South Korea
11.3.7.4.1 South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.4.2 South Korea Glioma Treatment Market, by Disease
11.3.7.4.3 South Korea Glioma Treatment Market, by Treatment Type
11.3.7.4.4 South Korea Glioma Treatment Market, by Grade
11.3.7.4.4.1 South Korea Glioma Treatment Market, by Low Grade
11.3.7.4.4.2 South Korea Glioma Treatment Market, by High Grade
11.3.7.4.5 South Korea Glioma Treatment Market, by End User
11.3.7.5 Australia
11.3.7.5.1 Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.5.2 Australia Glioma Treatment Market, by Disease
11.3.7.5.3 Australia Glioma Treatment Market, by Treatment Type
11.3.7.5.4 Australia Glioma Treatment Market, by Grade
11.3.7.5.4.1 Australia Glioma Treatment Market, by Low Grade
11.3.7.5.4.2 Australia Glioma Treatment Market, by High Grade
11.3.7.5.5 Australia Glioma Treatment Market, by End User
11.3.7.6 Rest of Asia Pacific
11.3.7.6.1 Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.6.2 Rest of Asia Pacific Glioma Treatment Market, by Disease
11.3.7.6.3 Rest of Asia Pacific Glioma Treatment Market, by Treatment Type
11.3.7.6.4 Rest of Asia Pacific Glioma Treatment Market, by Grade
11.3.7.6.4.1 Rest of Asia Pacific Glioma Treatment Market, by Low Grade
11.3.7.6.4.2 Rest of Asia Pacific Glioma Treatment Market, by High Grade
11.3.7.6.5 Rest of Asia Pacific Glioma Treatment Market, by End User
11.4 Middle East & Africa Glioma Treatment Market, Revenue and Forecast to 2030
11.4.1 Overview
11.4.2 Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3 Middle East & Africa Glioma Treatment Market, by Disease
11.4.4 Middle East & Africa Glioma Treatment Market, by Treatment Type
11.4.5 Middle East & Africa Glioma Treatment Market, by Grade
11.4.5.1 Middle East & Africa Glioma Treatment Market, by Low Grade
11.4.5.2 Middle East & Africa Glioma Treatment Market, by High Grade
11.4.6 Middle East & Africa Glioma Treatment Market, by End User
11.4.7 Middle East & Africa Glioma Treatment Market, by Country
11.4.7.1 Saudi Arabia
11.4.7.1.1 Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.1.2 Saudi Arabia Glioma Treatment Market, by Disease
11.4.7.1.3 Saudi Arabia Glioma Treatment Market, by Treatment Type
11.4.7.1.4 Saudi Arabia Glioma Treatment Market, by Grade
11.4.7.1.4.1 Saudi Arabia Glioma Treatment Market, by Low Grade
11.4.7.1.4.2 Saudi Arabia Glioma Treatment Market, by High Grade
11.4.7.1.5 Saudi Arabia Glioma Treatment Market, by End User
11.4.7.2 South Africa
11.4.7.2.1 South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.2.2 South Africa Glioma Treatment Market, by Disease
11.4.7.2.3 South Africa Glioma Treatment Market, by Treatment Type
11.4.7.2.4 South Africa Glioma Treatment Market, by Grade
11.4.7.2.4.1 South Africa Glioma Treatment Market, by Low Grade
11.4.7.2.4.2 South Africa Glioma Treatment Market, by High Grade
11.4.7.2.5 South Africa Glioma Treatment Market, by End User
11.4.7.3 UAE
11.4.7.3.1 UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.3.2 UAE Glioma Treatment Market, by Disease
11.4.7.3.3 UAE Glioma Treatment Market, by Treatment Type
11.4.7.3.4 UAE Glioma Treatment Market, by Grade
11.4.7.3.4.1 UAE Glioma Treatment Market, by Low Grade
11.4.7.3.4.2 UAE Glioma Treatment Market, by High Grade
11.4.7.3.5 UAE Glioma Treatment Market, by End User
11.4.7.4 Rest of Middle East & Africa
11.4.7.4.1 Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.4.2 Rest of Middle East & Africa Glioma Treatment Market, by Disease
11.4.7.4.3 Rest of Middle East & Africa Glioma Treatment Market, by Treatment Type
11.4.7.4.4 Rest of Middle East & Africa Glioma Treatment Market, by Grade
11.4.7.4.4.1 Rest of Middle East & Africa Glioma Treatment Market, by Low Grade
11.4.7.4.4.2 Rest of Middle East & Africa Glioma Treatment Market, by High Grade
11.4.7.4.5 Rest of Middle East & Africa Glioma Treatment Market, by End User
11.5 South & Central America Glioma Treatment Market, Revenue and Forecast to 2030
11.5.1 Overview
11.5.2 South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3 South & Central America Glioma Treatment Market, by Disease
11.5.4 South & Central America Glioma Treatment Market, by Treatment Type
11.5.5 South & Central America Glioma Treatment Market, by Grade
11.5.5.1 South & Central America Glioma Treatment Market, by Low Grade
11.5.5.2 South & Central America Glioma Treatment Market, by High Grade
11.5.6 South & Central America Glioma Treatment Market, by End User
11.5.6.1 South & Central America Glioma Treatment Market, by Country
11.5.6.2 Brazil
11.5.6.2.1 Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.2.2 Brazil Glioma Treatment Market, by Disease
11.5.6.2.3 Brazil Glioma Treatment Market, by Treatment Type
11.5.6.2.4 Brazil Glioma Treatment Market, by Grade
11.5.6.2.4.1 Brazil Glioma Treatment Market, by Low Grade
11.5.6.2.4.2 Brazil Glioma Treatment Market, by High Grade
11.5.6.2.5 Brazil Glioma Treatment Market, by End User
11.5.6.3 Argentina
11.5.6.3.1 Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.3.2 Argentina Glioma Treatment Market, by Disease
11.5.6.3.3 Argentina Glioma Treatment Market, by Treatment Type
11.5.6.3.4 Argentina Glioma Treatment Market, by Grade
11.5.6.3.4.1 Argentina Glioma Treatment Market, by Low Grade
11.5.6.3.4.2 Argentina Glioma Treatment Market, by High Grade
11.5.6.3.5 Argentina Glioma Treatment Market, by End User
11.5.6.4 Rest of South & Central America
11.5.6.4.1 Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.4.2 Rest of South & Central America Glioma Treatment Market, by Disease
11.5.6.4.3 Rest of South & Central America Glioma Treatment Market, by Treatment Type
11.5.6.4.4 Rest of South & Central America Glioma Treatment Market, by Grade
11.5.6.4.4.1 Rest of South & Central America Glioma Treatment Market, by Low Grade
11.5.6.4.4.2 Rest of South & Central America Glioma Treatment Market, by High Grade
11.5.6.4.5 Rest of South & Central America Glioma Treatment Market, by End User
12. Pre & Post Covid-19 Impact
12.1 Pre & Post Covid-19 Impact
13. Glioma Treatment Market Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Arbor Pharmaceuticals LLC
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Merck & Co Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Sun Pharmaceutical Industries Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Amgen Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Teva Pharmaceutical Industries Ltd
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Pfizer Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Amneal Pharmaceuticals Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Karyopharm Therapeutics Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Biocon Ltd
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About Us
15.2 Glossary of Terms
List of Tables
Table 1. Glioma Treatment Market Segmentation
Table 2. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 3. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 4. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 5. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 6. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 7. North America Glioma Treatment Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 8. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 9. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 10. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 11. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 12. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 13. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 14. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 15. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 16. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 17. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 18. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 19. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 20. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 21. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 22. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 23. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 24. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 25. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 26. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 27. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 28. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 29. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 30. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 31. Europe Glioma Treatment Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 32. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 33. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 34. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 35. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 36. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 37. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 38. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 39. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 40. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 41. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 42. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 43. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 44. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 45. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 46. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 47. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 48. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 49. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 50. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 51. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 52. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 53. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 54. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 55. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 56. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 57. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 58. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 59. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 60. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 61. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 62. Rest of Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 63. Rest of Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 64. Rest of Europe Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 65. Rest of Europe Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 66. Rest of Europe Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 67. Rest of Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 68. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 69. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 70. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 71. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 72. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 73. Asia Pacific Glioma Treatment Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 74. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 75. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 76. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 77. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 78. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 79. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 80. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 81. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 82. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 83. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 84. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 85. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 86. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 87. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 88. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 89. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 90. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 91. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 92. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 93. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 94. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 95. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 96. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – High Grade
Table 97. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 98. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 99. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 100. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 101. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 102. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 103. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 104. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 105. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 106. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 107. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 108. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 109. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 110. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 111. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 112. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 113. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 114. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 115. Middle East & Africa Glioma Treatment Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 116. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 117. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 118. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 119. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 120. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 121. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 122. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 123. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 124. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 125. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 126. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 127. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 128. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 129. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 130. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 131. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 132. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 133. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 134. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 135. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 136. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 137. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 138. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 139. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 140. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 141. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 142. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 143. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 144. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 145. South & Central America Glioma Treatment Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 146. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 147. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 148. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 149. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 150. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 151. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 152. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 153. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 154. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 155. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Low Grade
Table 156. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – High Grade
Table 157. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 158. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Disease
Table 159. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 160. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Grade
Table 161. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –Low Grade
Table 162. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) –High Grade
Table 163. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 164. Organic Developments Done By Companies
Table 165. Inorganic Developments Done By Companies
Table 166. Glossary of Terms, glioma treatment market
List of Figures
Figure 1. Glioma Treatment Market Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. Glioma Treatment Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Glioma Treatment Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Glioma Treatment Market Revenue, Geography (US$ Mn), 2022 – 2030
Figure 7. Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
Figure 8. Astrocytoma: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Oligodendroglioma: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Oligodendroglioma: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
Figure 12. Surgery: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Chemotherapy: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Radiation Therapy: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
Figure 17. Low Grade: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Grade I: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Grade II: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. High Grade: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Grade III: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Grade IV: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Hospital & Clinics: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Ambulatory Surgical Centers: Glioma Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Glioma Treatment Market, 2022 ($Mn)
Figure 27. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. North America Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 29. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Europe Glioma Treatment Market, By Geography, 2022 ($Mn)
Figure 33. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Europe Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 35. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 40. Rest of Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Glioma Treatment Market, By Geography, 2022 ($Mn)
Figure 42. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Asia Pacific Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 44. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 46. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 48. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 49. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 50. Glioma Treatment Market, By Geography, 2022 ($Mn)
Figure 51. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. Middle East & Africa Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 53. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 56. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. Glioma Treatment Market, By Geography, 2022 ($Mn)
Figure 58. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. South & Central America Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 60. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 61. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 62. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 63. Pre & Post Covid-19 Impact
Figure 64. Growth Strategies Done by the Companies in the Market, (%)
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For